CCR5 ligand-positive cells were detected at >5-fold higher levels in the fibrotic dermis of SSc patients (Figure 6) and Pump Model mice (Figure 7) than in control dermis where almost no double-positive cells were detected. This evidence concerns the gene CCR5 and systemic sclerosis.